ID25640A - Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya - Google Patents

Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya

Info

Publication number: ID25640A
Authority: ID; Indonesia
Prior art keywords: antagonistics; preparates; aii; production; continuous release
Prior art date: 1998-03-04

Application number

IDW20001680A

Other languages

English (en)

Inventor

Yasutaka Igari

Akira Saikawa

Yoshiyuki Inada

Shigeru Kamei

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-04

Filing date

1999-03-03

Publication date

2000-10-19

1999-03-03 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2000-10-19 Publication of ID25640A publication Critical patent/ID25640A/id

Links

102000005862 Angiotensin II Human genes 0.000 abstract 2
101800000733 Angiotensin-2 Proteins 0.000 abstract 2
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 2
229950006323 angiotensin ii Drugs 0.000 abstract 2
230000003042 antagnostic effect Effects 0.000 abstract 2
229920002988 biodegradable polymer Polymers 0.000 abstract 1
239000004621 biodegradable polymer Substances 0.000 abstract 1
230000036772 blood pressure Effects 0.000 abstract 1
230000027288 circadian rhythm Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003405 delayed action preparation Substances 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IDW20001680A 1998-03-04 1999-03-03 Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya ID25640A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP5236698		1998-03-04

Publications (1)

Publication Number	Publication Date
ID25640A true ID25640A (id)	2000-10-19

Family

ID=12912818

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20001680A ID25640A (id)	1998-03-04	1999-03-03	Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya

Country Status (21)

Country	Link
US (2)	US6589547B1 (id)
EP (1)	EP1058541B1 (id)
KR (1)	KR20010086245A (id)
CN (1)	CN1291888A (id)
AT (1)	ATE258430T1 (id)
AU (1)	AU2745199A (id)
BR (1)	BR9908474A (id)
CA (1)	CA2318446C (id)
DE (1)	DE69914460T2 (id)
EE (1)	EE200000499A (id)
ES (1)	ES2214013T3 (id)
HU (1)	HUP0101439A3 (id)
ID (1)	ID25640A (id)
IL (1)	IL137979A0 (id)
LT (1)	LT4800B (id)
LV (1)	LV12585B (id)
NO (1)	NO20004350L (id)
PL (1)	PL342684A1 (id)
SK (1)	SK11902000A3 (id)
WO (1)	WO1999044590A1 (id)
ZA (1)	ZA991706B (id)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69914460T2 (de) *	1998-03-04	2004-10-28	Takeda Chemical Industries, Ltd.	Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung
CN1172719C (zh)	1999-04-28	2004-10-27	武田药品工业株式会社	单纯性视网膜病或前增殖性视网膜病的预防剂、治疗剂、发展抑制剂
SE9903028D0 (sv) *	1999-08-27	1999-08-27	Astra Ab	New use
BR0013704A (pt)	1999-08-30	2002-05-07	Aventis Pharma Gmbh	Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares
KR20030016229A (ko) *	2000-02-18	2003-02-26	다케다 야쿠힌 고교 가부시키가이샤	ＴＮＦ-α 억제제
AU2001232348A1 (en) *	2000-02-21	2001-08-27	Takeda Chemical Industries Ltd.	Sustained release preparations of physiologically active compound hardly solublein water and production process and use of the same
CA2420055C (en) *	2000-08-25	2010-06-01	Takeda Chemical Industries, Ltd.	Fibrinogen-lowering agent
AU2002210925A1 (en) *	2000-10-25	2002-05-06	Takeda Chemical Industries Ltd.	Preventives/remedies for portal hypertension
US20040121008A1 (en) *	2001-03-16	2004-06-24	Keiko Shiraishi	Process for producing sustained release preparation
CA2456034A1 (en) *	2001-08-03	2003-02-20	Takeda Chemical Industries, Ltd.	Sustained-release medicines
BRPI0105509B8 (pt) *	2001-11-05	2021-05-25	Univ Minas Gerais	formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
WO2003041739A1 (fr)	2001-11-13	2003-05-22	Takeda Chemical Industries, Ltd.	Agents anticancer
EP1452176A4 (en) *	2001-12-03	2009-01-21	Takeda Pharmaceutical	AGENTS FOR IMPROVING THE STATE OF RESISTANCE OF INSULIN
US7700074B2 (en) *	2002-02-07	2010-04-20	Pettegrew Jay W	Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US7407778B2 (en) *	2002-02-07	2008-08-05	Pettegrew Jay W	Compounds, compositions and methods for treating neuropsychiatric disorders
CN100438911C (zh) *	2002-12-27	2008-12-03	武田药品工业株式会社	体重增加抑制剂
US20050038093A1 (en) *	2003-05-02	2005-02-17	Boehringer Ingelheim International Gmbh	Treating diabetic retinopathy with angiotensin II receptor blockers
CN1795198B (zh) *	2003-05-29	2011-08-17	杰伊·W·佩特格尤	对神经精神疾病进行医学成像所用的甘油磷酸胆碱及其衍生物
US20060257842A1 (en) *	2003-05-29	2006-11-16	Pettegrew Jay W	Cryopreservation media and molecules
WO2005097109A1 (en) *	2004-04-01	2005-10-20	Daniel Batlle	Methods for achieving a protective ace2 expression level
EP1750862B1 (en)	2004-06-04	2011-01-05	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
AU2005290394A1 (en) *	2004-10-07	2006-04-13	Takeda Pharmaceutical Company Limited	Agent for prophylaxis or treatment of metabolic syndrome
KR20070074576A (ko) *	2004-10-29	2007-07-12	코와 가부시키가이샤	사구체 질환 치료제
CA2598410A1 (fr) *	2005-02-21	2006-08-24	Flamel Technologies	Forme pharmaceutique orale de losartan
HRP20080552A9 (en) *	2005-03-30	2009-08-31	Takeda Pharmaceutical Company Limited	Benzimidazole derivative and use thereof
JP2009504800A (ja) *	2005-08-22	2009-02-05	アレンビクリミテッド	バルサルタンの調製方法
WO2008018569A1 (en) *	2006-08-10	2008-02-14	Takeda Pharmaceutical Company Limited	Pharmaceutical composition
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
EP1897537A1 (en) *	2006-09-04	2008-03-12	Novartis AG	Composition comprising an angiotensin II receptor antagonist
EP1908469A1 (en)	2006-10-06	2008-04-09	Boehringer Ingelheim Vetmedica Gmbh	Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
NO347209B1 (no)	2006-12-18	2023-07-03	Takeda Pharmaceutical	Sammensetning med forlenget frigjøring og fremgangsmåte for å produsere det samme
CN101011393B (zh) *	2007-02-16	2010-10-06	广州柏赛罗药业有限公司	厄贝沙坦胃内滞留型缓释药物组合物
CA2681143C (en) *	2007-03-28	2017-01-03	Takeda Pharmaceutical Company Limited	Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
CN102065847A (zh) *	2008-04-29	2011-05-18	韩诺生物制约株式会社	含有血管紧张素-ⅱ受体阻断剂的药物制剂
WO2010133638A1 (de)	2009-05-20	2010-11-25	Boehringer Ingelheim Vetmedica Gmbh	Pharmazeutische telmisartan-trinklösung
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2751907A (en) *	1953-09-18	1956-06-26	Bishop & Co Platinum Works J	Pellet injector
JPS5671073A (en)	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	Imidazole derivative
JPS5671074A (en)	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
IE802177L (en)	1980-10-21	1981-05-12	Takeda Chemical Industries Ltd	Imidazol-5-ylacetic acid derivatives
JPS58157768A (ja)	1982-03-16	1983-09-19	Takeda Chem Ind Ltd	４−クロロ−２−フエニルイミダゾ−ル−５−酢酸誘導体
CA1334092C (en)	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
US4820843A (en)	1987-05-22	1989-04-11	E. I. Du Pont De Nemours And Company	Tetrazole intermediates to antihypertensive compounds
US5015651A (en)	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en)	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
CA1338238C (en)	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4898732A (en) *	1988-05-04	1990-02-06	The Clinipad Corporation	Inhibiting of tumor growth with an antagonist of the renin-angioten-sin system
DE3928177A1 (de)	1989-04-08	1991-02-28	Thomae Gmbh Dr K	Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IE64514B1 (en)	1989-05-23	1995-08-09	Zeneca Ltd	Azaindenes
ATE107517T1 (de) *	1989-05-25	1994-07-15	Takeda Chemical Industries Ltd	Transdermales therapeutisches mittel.
CA2018443A1 (en)	1989-06-14	1990-12-14	Joseph A. Finkelstein	Imidazolyl-alkenoic acids
DE69025473T2 (de)	1989-06-30	1996-10-17	Du Pont	Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
CA2020073A1 (en)	1989-07-03	1991-01-04	Eric E. Allen	Substituted quinazolinones as angiotensin ii antagonists
EP0407342A3 (en)	1989-07-06	1991-07-10	Ciba-Geigy Ag	Pyrimidine derivatives
EP0409332A3 (en)	1989-07-19	1991-08-07	Merck & Co. Inc.	Substituted triazoles as angiotensin ii antagonists
US5225205A (en) *	1989-07-28	1993-07-06	Debiopharm S.A.	Pharmaceutical composition in the form of microparticles
DE69013607T2 (de)	1989-08-02	1995-03-02	Takeda Chemical Industries Ltd	Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
IL95975A (en)	1989-10-24	1997-06-10	Takeda Chemical Industries Ltd	N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
EP0434038A1 (en)	1989-12-22	1991-06-26	Takeda Chemical Industries, Ltd.	Fused imidazole derivatives, their production and use
EP0442473B1 (en)	1990-02-15	1998-08-19	Takeda Chemical Industries, Ltd.	Pyrimidinedione derivatives, their production and use
CA2036618C (en) *	1990-02-22	2002-10-29	Akira Morimoto	Fused thiophene derivatives, their production and use
IE912956A1 (en) *	1990-09-10	1992-03-11	Abbott Lab	Angiotensin ii receptor antagonists
US5171217A (en) *	1991-02-28	1992-12-15	Indiana University Foundation	Method for delivery of smooth muscle cell inhibitors
TW274551B (id)	1991-04-16	1996-04-21	Takeda Pharm Industry Co Ltd
CZ36394A3 (en) *	1991-08-19	1994-07-13	Du Pont	Substituted imidazilonone derivatives and pharmaceutical preparations based thereon
TW284688B (id) *	1991-11-20	1996-09-01	Takeda Pharm Industry Co Ltd
US5656297A (en)	1992-03-12	1997-08-12	Alkermes Controlled Therapeutics, Incorporated	Modulated release from biocompatible polymers
GB2272899A (en) *	1992-11-30	1994-06-01	Du Pont Merck Pharma	Angiotensin-11 receptor blocking cycloalkylbenzylimidazoles
EP0603712B1 (en)	1992-12-22	2001-08-16	Takeda Chemical Industries, Ltd.	Heterocyclic compounds having angiotensin II antagonistic activity and use thereof
US5288720A (en) *	1993-04-23	1994-02-22	American Cyanamid Company	Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5721263A (en) *	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
NZ268326A (en) *	1993-07-19	1997-12-19	Angiogenesis Tech Inc	Stent with a coating comprising an anti-angiogenic compound, such as taxol, and a polymeric carrier
JPH0789849A (ja)	1993-09-20	1995-04-04	Fujisawa Pharmaceut Co Ltd	徐放性製剤
ATE268591T1 (de) *	1995-06-27	2004-06-15	Takeda Chemical Industries Ltd	Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
CN1214682A (zh)	1996-03-29	1999-04-21	史密丝克莱恩比彻姆公司	Eprosartan二水合物及其制备和制剂方法
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
US6201002B1 (en) *	1997-01-10	2001-03-13	Merck & Co., Inc.	Method for reducing mortality with an angiotensin II antagonist
US5958884A (en) *	1997-04-11	1999-09-28	The Brigham And Women's Hospital, Inc.	Compositions and methods for treating erectile dysfunction
US6306826B1 (en) *	1997-06-04	2001-10-23	The Regents Of The University Of California	Treatment of heart failure with growth hormone
DE19741635A1 (de) *	1997-09-22	1999-03-25	Hoechst Marion Roussel De Gmbh	Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE69914460T2 (de) *	1998-03-04	2004-10-28	Takeda Chemical Industries, Ltd.	Zubereitung mit verzögerter wirkstoffabgabe für aii antagonisten, ihre herstellung und verwendung

1999
- 1999-03-03 DE DE69914460T patent/DE69914460T2/de not_active Expired - Lifetime
- 1999-03-03 SK SK1190-2000A patent/SK11902000A3/sk unknown
- 1999-03-03 ES ES99907846T patent/ES2214013T3/es not_active Expired - Lifetime
- 1999-03-03 EE EEP200000499A patent/EE200000499A/xx unknown
- 1999-03-03 ID IDW20001680A patent/ID25640A/id unknown
- 1999-03-03 AT AT99907846T patent/ATE258430T1/de not_active IP Right Cessation
- 1999-03-03 HU HU0101439A patent/HUP0101439A3/hu unknown
- 1999-03-03 CA CA002318446A patent/CA2318446C/en not_active Expired - Fee Related
- 1999-03-03 CN CN99803444A patent/CN1291888A/zh active Pending
- 1999-03-03 EP EP99907846A patent/EP1058541B1/en not_active Expired - Lifetime
- 1999-03-03 ZA ZA9901706A patent/ZA991706B/xx unknown
- 1999-03-03 WO PCT/JP1999/001011 patent/WO1999044590A1/en not_active Ceased
- 1999-03-03 BR BR9908474-0A patent/BR9908474A/pt not_active IP Right Cessation
- 1999-03-03 PL PL99342684A patent/PL342684A1/xx unknown
- 1999-03-03 IL IL13797999A patent/IL137979A0/xx unknown
- 1999-03-03 KR KR1020007008919A patent/KR20010086245A/ko not_active Abandoned
- 1999-03-03 AU AU27451/99A patent/AU2745199A/en not_active Abandoned
- 1999-03-09 US US09/601,986 patent/US6589547B1/en not_active Expired - Fee Related
2000
- 2000-08-16 LV LVP-00-110A patent/LV12585B/en unknown
- 2000-08-31 LT LT2000082A patent/LT4800B/lt not_active IP Right Cessation
- 2000-09-01 NO NO20004350A patent/NO20004350L/no unknown
2003
- 2003-05-22 US US10/443,308 patent/US7294344B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0101439A3 (en)	2002-09-30
NO20004350D0 (no)	2000-09-01
US6589547B1 (en)	2003-07-08
CA2318446C (en)	2008-09-23
LV12585B (en)	2001-03-20
KR20010086245A (ko)	2001-09-10
LT2000082A (en)	2001-03-26
DE69914460T2 (de)	2004-10-28
ZA991706B (en)	2000-10-03
NO20004350L (no)	2000-10-03
DE69914460D1 (de)	2004-03-04
AU2745199A (en)	1999-09-20
BR9908474A (pt)	2000-12-05
LV12585A (en)	2000-12-20
ATE258430T1 (de)	2004-02-15
SK11902000A3 (sk)	2001-02-12
EE200000499A (et)	2002-02-15
EP1058541A1 (en)	2000-12-13
CA2318446A1 (en)	1999-09-10
WO1999044590A1 (en)	1999-09-10
US20030198676A1 (en)	2003-10-23
CN1291888A (zh)	2001-04-18
IL137979A0 (en)	2001-10-31
EP1058541B1 (en)	2004-01-28
HUP0101439A2 (hu)	2001-10-28
PL342684A1 (en)	2001-07-02
ES2214013T3 (es)	2004-09-01
US7294344B2 (en)	2007-11-13
LT4800B (lt)	2001-06-25

Publication	Publication Date	Title
ID25640A (id)	2000-10-19	Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya
ID24423A (id)	2000-07-20	Sediaan farmasi yang terdiri dari klodronat sebagai bahan aktif dan selulosa mikrokristalin tersilisifikasi sebagai eksipien
FI973452A7 (fi)	1997-08-22	Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
TR200101859T2 (tr)	2001-12-21	Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
EA200101155A1 (ru)	2002-10-31	Противоопухолевые соединения, активируемые протеином активации фибробластов (fap)
BR0108471A (pt)	2002-10-29	Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente
BR0014651A (pt)	2002-06-18	Inibidores de adesão de célula mediada por "alfa" l beta2
DE60140222D1 (de)	2009-11-26	"2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
ATE302606T1 (de)	2005-09-15	N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
ATE170508T1 (de)	1998-09-15	Bisulfit-additionsverbindungen von argininaldehyden und ihre verwendung als thrombininhibitoren und antikoagulantien
ID20511A (id)	1999-01-07	Sulfonamida, pembuatan dan penggunaannya sebagai bahan herbisida dan bahan pengatur pertumbuhan tanaman
DK0689841T3 (da)	2003-02-24	Pulverpræparat til heling af beskadiget hud
ATE435648T1 (de)	2009-07-15	Derivaten von nodulisporen säure
BG66115B1 (bg)	2011-05-31	Използване на рамиприл или негова фармацевтично приемлива сол за предотвратяване на конгестивна сърдечна недостатъчност
DE69840645D1 (en)	2009-04-23	Benzamidinderivate
BR0101264A (pt)	2001-11-06	Derivados de diazepan ou seus sais
EP1350511A4 (en)	2004-06-23	MEDICAL COMPOSITIONS CONTAINING ASPIRIN
BR9804027A (pt)	2001-04-24	Novos beta-ceto ésteres
BR0214299A (pt)	2004-12-14	Peptìdeo, inibidor de enzima de conversão de angiotensina, e, agente hipotensivo
BR9910539A (pt)	2001-01-16	Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
EA200100089A1 (ru)	2001-08-27	Предотвращение рецидива мигрени
BR9812982A (pt)	2000-08-08	Agente anti-reumático
EP1062949A4 (en)	2002-10-09	IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS
ES2133702T3 (es)	1999-09-16	Agente herbicida selectivo.
ATE465718T1 (de)	2010-05-15	Feste pharmazeutische zubereitung enthaltend levothyroxin- und/oder liothyroninsalze